ZA951789B - Pharmaceutical materials and methods of administration - Google Patents

Pharmaceutical materials and methods of administration

Info

Publication number
ZA951789B
ZA951789B ZA951789A ZA951789A ZA951789B ZA 951789 B ZA951789 B ZA 951789B ZA 951789 A ZA951789 A ZA 951789A ZA 951789 A ZA951789 A ZA 951789A ZA 951789 B ZA951789 B ZA 951789B
Authority
ZA
South Africa
Prior art keywords
administration
methods
pharmaceutical materials
pharmaceutical
materials
Prior art date
Application number
ZA951789A
Other languages
English (en)
Inventor
Ronald W Pero
Original Assignee
Oxigene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxigene Inc filed Critical Oxigene Inc
Publication of ZA951789B publication Critical patent/ZA951789B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA951789A 1994-03-25 1995-03-03 Pharmaceutical materials and methods of administration ZA951789B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/218,072 US5561161A (en) 1994-03-25 1994-03-25 Methods of administering and pharmaceutical formulations containing n-substituted benzamides and/or acid addition salts thereof

Publications (1)

Publication Number Publication Date
ZA951789B true ZA951789B (en) 1995-12-11

Family

ID=22813628

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA951789A ZA951789B (en) 1994-03-25 1995-03-03 Pharmaceutical materials and methods of administration

Country Status (9)

Country Link
US (2) US5561161A (xx)
EP (1) EP0754037A4 (xx)
JP (1) JPH07277965A (xx)
AU (1) AU702675B2 (xx)
CA (1) CA2182952A1 (xx)
IL (1) IL113110A (xx)
TW (1) TW436287B (xx)
WO (1) WO1995026186A1 (xx)
ZA (1) ZA951789B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713517B1 (en) 1996-03-08 2004-03-30 Oxigene, Inc. Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such use
HU229875B1 (en) 1999-01-11 2014-11-28 Agouron Pharmaceuticals Inc La Jolla Tricyclic inhibitors of poly(adp-ribose) polymerases
ECSP003637A (es) 1999-08-31 2002-03-25 Agouron Pharma Inhibidores triciclicos de poli (adp-ribosa) polimerasas
BR0209965A (pt) 2001-05-21 2004-04-06 Alcon Inc Uso de inibidores de nf-kappab para tratar distúrbios do olho seco

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR127M (fr) * 1960-07-15 1961-02-06 Prod Chim Et De Synthese Soc D Médicaments nouveaux pour calcithérapie.
US4602807A (en) * 1984-05-04 1986-07-29 Rudy Bowers Rod coupling for oil well sucker rods and the like
GB8412585D0 (en) * 1984-05-17 1984-06-20 Beecham Group Plc Composition
US4624965A (en) * 1984-11-15 1986-11-25 Nastech Pharmaceutical Co., Inc. Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same
FI871447A (fi) * 1986-04-07 1987-10-08 Bristol Myers Co Stabila injicerbara antivomitiva kompositioner.

Also Published As

Publication number Publication date
AU2095695A (en) 1995-10-17
AU702675B2 (en) 1999-03-04
CA2182952A1 (en) 1995-10-05
IL113110A (en) 1999-12-22
WO1995026186A1 (en) 1995-10-05
JPH07277965A (ja) 1995-10-24
IL113110A0 (en) 1995-06-29
EP0754037A1 (en) 1997-01-22
EP0754037A4 (en) 2002-10-23
MX9603766A (es) 1997-12-31
TW436287B (en) 2001-05-28
US5561161A (en) 1996-10-01
US5561129A (en) 1996-10-01

Similar Documents

Publication Publication Date Title
PL330814A1 (en) Compounds for and methods of delivering pharmaceutical preparations and their application
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
GB2313310B (en) Local delivery and monitoring of drugs
ZA966494B (en) New drugs and their use
AU1970495A (en) Drug delivery device and method of construction
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
PL321003A1 (en) Derivatives of piperasine, drugs containing them, their application and methods of obtaining them
IL114925A0 (en) Glycinamide derivatives their preparation and pharmaceutical compositions containing them
GB2286393B (en) Piperazinedione derivatives and pharmaceutical uses thereof
HU9602671D0 (en) Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
ZA984266B (en) Pharmaceutical composition and process of preparation
ZA967800B (en) Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
HUP9602196A3 (en) Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof
ZA9711129B (en) New analogues of camptothecin their medical application and the pharmaceutical substances that contain them
GB9601186D0 (en) Administration of Drugs
GB9501286D0 (en) Pharmaceutical compositions and preparations thereof
ZA951789B (en) Pharmaceutical materials and methods of administration
HUP9602220A3 (en) Substituted 4h-piranes and pharmaceutical preparations containing them
GB9302553D0 (en) Pharmaceutical preparations and their manufacture and use
PL318256A1 (en) Drug containing derivatives of tetrahydroisoquinoline and novel derivatives of tetrahydroisoquinoline
IL116012A0 (en) 6-methoxy-1h-benzotriazole-5 carboxamide derivatives their preparation and pharmaceutical compositions containing them
GB9401745D0 (en) Improvements in and relating to the administration of medicaments or therapeutic substances
AU5553294A (en) Novel substance dolastatin c and pharmaceutical use thereof
GB2286529B (en) Combinations of class III antiarrhythmic drug (+)-Sotalol and class II antiarrhythmic drugs
AU698359C (en) Pharmaceutical preparations and medicinal substances for the prevention and treatment of endothelial dysfunctions